News|Articles|March 31, 2025
Q1 Dermatology Drug & Device Report: FDA Approvals & Pipeline Updates
Author(s)Emma Andrus, Editor
Exclusive Q1 Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first quarter of 2025.
Advertisement
Advertisement
The first quarter of 2025 saw significant developments in the dermatology specialty, with key decisions from the US FDA and a flurry of submissions, trial advancements, and regulatory actions from various organizations driving the pipeline forward.
Advertisement
Advertisement